DS
EVH icon

David Shaw’s Evolent Health EVH Stock Holding History

David Shaw’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-61,500
Closed -$692K – 4391
2024
Q4 		$692K Hold
61,500
– – ﹤0.01% 3424
2024
Q3 		$1.74M Buy
+61,500
New +$1.59M ﹤0.01% 2810
2022
Q2 		– Sell
-20,000
Closed -$646K – 5446
2022
Q1 		$646K Hold
20,000
– – ﹤0.01% 4214
2021
Q4 		$553K Buy
+20,000
New +$574K ﹤0.01% 4345

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's EVH Position: Q2 2026 in Review

David Shaw reduced its Evolent Health (EVH) stake by 6% in Q2 2026, selling an estimated $1.25M and leaving 5,107,561 shares worth $27.7M. The position accounts for 0.01% of the portfolio, ranked #1086.

David Shaw first reported a position in EVH in Q3 2015 and has held it in 29 quarters since. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • David Shaw held 5,107,561 shares of Evolent Health worth $27.7M as of Q2 2026.
  • David Shaw sold 326,471 Evolent Health shares in Q2 2026, an estimated $1.25M.
  • Evolent Health made up 0.01% of David Shaw's portfolio in Q2 2026, its #1086 holding.
  • David Shaw first reported a position in Evolent Health in Q3 2015 and has held it in 29 quarters since.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.